← Back to Search

Other

Intervention for Attention Deficit Hyperactivity Disorder (ADHD)

N/A
Recruiting
Led By William Brinkman, MD, MEd, MSc
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected at study visit 2 (which is 4-12 weeks after study visit 1).
Awards & highlights

Study Summary

This trial aims to test personalized medication experiments to help make decisions about future medication use for adolescents. The researchers believe that their intervention will increase the adolescents' involvement in decision making and reduce uncertainty about future medication

Who is the study for?
This trial is for adolescents with ADHD who are interested in exploring how personalized medication can affect their condition. It's a pilot study, meaning it's an early test to see if the approach works and is accepted by participants.Check my eligibility
What is being tested?
The study tests a new way of using ADHD medication tailored to each individual. The goal is to involve teens more in decision-making about their treatment and reduce uncertainty regarding future medication use.See study design
What are the potential side effects?
Since specific medications aren't listed, potential side effects cannot be detailed here. However, common ADHD medication side effects include sleep problems, decreased appetite, mood swings, and increased heart rate.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected at study visit 1 and 4-12 weeks later at study visit 2.
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected at study visit 1 and 4-12 weeks later at study visit 2. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Behavioral Intention Questions
Decision-Making Involvement Scale
Decisional Conflict Scale (DCS)
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All will choose one of five medication experiment options to complete.

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
815 Previous Clinical Trials
6,531,561 Total Patients Enrolled
33 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
4,037 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
William Brinkman, MD, MEd, MScPrincipal InvestigatorCincinnati Children's
1 Previous Clinical Trials
85 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
85 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment phase for this medical study currently ongoing?

"As per clinicaltrials.gov, this study is actively seeking volunteers. The trial was initially shared on November 10th, 2023 and underwent its latest revision on March 7th, 2024."

Answered by AI

Is there an age limit excluding those above 85 years from participating in this study?

"Patients eligible for this research must fall within the age range of 11 to 15. There are a total of 120 trials tailored for individuals younger than 18 and an additional 38 focused on those above the age of 65."

Answered by AI
~13 spots leftby Aug 2024